Search Ontology:
ChEBI
canagliflozin
- Term ID
- CHEBI:73274
- Synonyms
-
- (1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol
- 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene
- Definition
- A C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2.
- References
-
- cas:842133-18-0
- drugcentral:4758
- patent:US2008146515
- patent:US2010099883
- patent:US2012289694
- patent:WO2009035969
- patent:WO2011142478
- pubmed:20690635
- pubmed:21457428
- pubmed:22226086
- pubmed:22355316
- pubmed:22385274
- pubmed:22492586
- pubmed:22548646
- pubmed:22621689
- pubmed:22632452
- pubmed:23087012
- pubmed:23279307
- pubmed:23370138
- pubmed:23412078
- pubmed:23464594
- pubmed:23563279
- pubmed:23564919
- pubmed:23585665
- pubmed:23590413
- reaxys:18362681
- wikipedia.en:Canagliflozin
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from canagliflozin
Phenotype where environments contain canagliflozin
Phenotype modified by environments containing canagliflozin
Phenotype affecting canagliflozin
Human Disease Model